Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06858449 · ClinicalTrials.gov registry record · NA

Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

A NA study of Breast Cancer and Cancer, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06858449: Recruiting NA study of Breast Cancer and Cancer, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

NCT06858449 is a NA study of Breast Cancer and Cancer that is actively recruiting participants, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 30 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06858449, a NA study of Breast Cancer and Cancer, is actively recruiting participants, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Whey protein (20 grams)
  • DIETARY_SUPPLEMENT Whey protein (60 grams)

Study Locations (1)

Pennsylvania

  • Allegheny General Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-01-02
Est. Completion 2027-03
Phase NA

What the Registry Record Tells You About NCT06858449

The ClinicalTrials.gov registry entry for NCT06858449 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Whey protein (20 grams) is the first listed.

NCT06858449 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06858449 about?

NCT06858449 is a clinical study titled "Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer". In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.

What is the current status of trial NCT06858449?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-01-02. Estimated completion is 2027-03.

What conditions does trial NCT06858449 study?

This clinical trial studies the following conditions: Breast Cancer, Cancer.

What interventions are being tested in trial NCT06858449?

The interventions under investigation include: Whey protein (20 grams) (DIETARY_SUPPLEMENT), Whey protein (60 grams) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06858449?

This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06858449 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.